BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 18, 2011
 |  BC Week In Review  |  Company News  |  Deals

Cellectar, Novelos deal

Cancer company Novelos acquired radiopharmaceutical company Cellectar in a stock deal valued at $64.4 million based on Novelos' close of $3.79 on April 8, before the deal was announced. Cellectar shareholders received 17 million Novelos shares after Novelos implemented a 1-for-153 reverse stock split which...

Read the full 202 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >